-
Cancer Did Not Cancel Our Plans
After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.
by Miriam Díaz-Gilbert
-
March 12: The Week in Cancer News
Lung cancer screening recommendations expand to include more smokers, and a U.K. study finds cancer patients may be less protected from COVID-19 than people without cancer after the first dose of the Pfizer-BioNTech vaccine.
by Kevin McLaughlin
-
A Drive for Diversity
African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
March 5: The Week in Cancer News
A patient advocate and researcher argue that the U.S. has set insufficiently ambitious cervical cancer screening goals, and Merck withdraws the small cell lung cancer indication for its immunotherapy drug Keytruda.
by Kate Yandell
-
Survival Statistics 101
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
-
February 26: The Week in Cancer News
Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.
by Bradley Jones
-
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
February 19: The Week in Cancer News
Organizations call to prioritize cancer patients for COVID-19 vaccination, researchers analyze rates of “low-value” breast surgeries, and UCLA cancer survivors write letters to patients undergoing treatment.
by Marci A. Landsmann
-
Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
-
February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and physicians warn that enlarged lymph nodes after COVID-19 vaccination can be mistaken for signs of breast cancer.
by Kate Yandell
Cancer Talk
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin